Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Brain Tumor
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04178057
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Wenbin Li, Ph.D Beijing Tiantan Hospital of Capital Medical University
Get Well Soon